Toxicological Status of Children with Autism vs. Neurotypical Children and the Association with Autism Severity
- 1.4k Downloads
This study investigates both the level of toxic metals in children with autism and the possible association of those toxic metals with autism severity. This study involved 55 children with autism ages 5–16 years compared to 44 controls with similar age and gender. The study included measurements of toxic metals in whole blood, red blood cells (RBC), and urine. The autism group had higher levels of lead in RBC (+41 %, p = 0.002) and higher urinary levels of lead (+74 %, p = 0.02), thallium (+77 %, p = 0.0001), tin (+115 %, p = 0.01), and tungsten (+44 %, p = 0.00005). However, the autism group had slightly lower levels of cadmium in whole blood (−19 %, p = 0.003). A stepwise, multiple linear regression analysis found a strong association of levels of toxic metals with variation in the degree of severity of autism for all the severity scales (adjusted R 2 of 0.38–0.47, p < 0.0003). Cadmium (whole blood) and mercury (whole blood and RBC) were the most consistently significant variables. Overall, children with autism have higher average levels of several toxic metals, and levels of several toxic metals are strongly associated with variations in the severity of autism for all three of the autism severity scales investigated.
KeywordsAutism Toxic metals Mercury Lead Thallium Tungsten
First and foremost, we thank the many autism families and their friends who volunteered as participants in this research study. We thank the Autism Society of Greater Phoenix and the Arizona Division of Developmental Disabilities for assistance with advertising this study. We thank the staff of the Southwest College of Naturopathic Medicine (N. Foster, M. Harland, B. Peterson, N. Tkacenko) for the help with phlebotomy, and we thank ICDRC for providing use of their offices for participant visits. We thank Vitamin Diagnostics and Doctor’s Data for providing testing for this study. We thank Jon Pangborn for commenting on the manuscript.
Declaration of Competing Interests
The authors declare that they have no competing interests.
This work was supported by the Autism Research Institute and the Legacy Foundation.
- 2.James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141:947–956Google Scholar
- 3.James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW (2009) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89((1):425–430, Epub 2008 Dec 3Google Scholar
- 4.Adams JB, Audhya T, Mcdonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8(1):34, Jun 8CrossRefGoogle Scholar
- 6.Adams JB, Holloway CE, Margolis M, George F (2003) Heavy metal exposures, developmental milestones, and physical symptoms in children with autism. Conference Proceedings of the Fall 2003 Defeat Autism Now! Conference on Oct 3–5, 2003 in Portland, Oregon, p. 71–75.Google Scholar
- 17.Ash MM, Nelson SJ (2003) Wheeler’s dental anatomy, physiology and occlusion, 8th edn. Elsevier, St LouisGoogle Scholar
- 19.Geier DA, Audhya T, Kern JK, Geier MR (2010) Blood mercury levels in autism spectrum disorder: is there a threshold level? Acta Neurobiol Exp (Wars) 70(2):177–186Google Scholar
- 22.Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR (2003) A case–control study of mercury burden in children with autistic spectrum disorders. J Am Phys Surg 8(3):76–79Google Scholar
- 28.Woods JS, Armel SE, Fulton DI, Allen J, Wessels K, Simmonds PL, Granpeesheh D, Mumper E, Bradstreet JJ, Echeverria D, Heyer NJ, Rooney JP (2010) Urinary porphyrin excretion in neurotypical and autistic children. Environ Health Perspect 118(10)):1450–1457, Epub 2010 Jun 24PubMedCrossRefGoogle Scholar
- 33.Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr JM (2009) The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol 2009(532640):7. doi: 10.1155/2009/532640 Google Scholar
- 34.Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J (2009) Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A—medical results. BMC Clin Pharmacol 9:16PubMedCrossRefGoogle Scholar
- 35.Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J (2009) Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B—behavioral results. BMC Clin Pharmacol 9:17PubMedCrossRefGoogle Scholar
- 38.Rimland B and Edelson S (2000) Autism treatment evaluation checklist: statistical analyses, Autism Research InstituteGoogle Scholar
- 39.de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51(4):418–424PubMedCrossRefGoogle Scholar